According to the US Centers for Disease Control and Prevention, US efforts to promote COVID-19 vaccines continue to have success on Wednesday with 19% of the population now fully vaccinated, according to the Center. Disease Control and Prevention, although experts are concerned that the number of cases continues to rise.
The CDC’s vaccine tracker shows that at 6 a.m. ET Tuesday, 219 million doses had been shipped to the states, 168.6 million doses had been administered, and 108.3 million Americans had received at least one, equaling 32.6% of the general population.
At least 63 million people were fully vaccinated, meaning they received two doses of the vaccine from Pfizer Inc.
In the age group 65 and older, 30.9 million people were fully vaccinated, more than half – 56.6% – of that group.
The US added at least 62,004 new cases on Tuesday, according to a New York Times follower, and at least 907 people died. The seven-day average was 64,847 cases a day, up 19% from the 14-day average.
Minnesota and Illinois are seeing rapid case increases, while the six major metropolitan areas with the highest incidence of new cases are all located. in Michigan, monitor display. But all states in the Northeast Corridor are now seeing cases of increase and remain high, including New York, New Jersey, Rhode Island, Pennsylvania and Massachusetts.
According to Dr. Rochelle Walensky, CDC director, variant B.1.1.7, first identified in the UK, is currently the most dominant form of coronavirus circulating in the US, according to Dr. Rochelle Walensky, director of the CDC. Research indicates that this strain is more contagious and more deadly.
“The virus is still clinging to us,” she said during a meeting at the White House. “We need to be vigilant.”
CDC said in January that B.1.1.7 will be the most common virus by the end of March.
Walensky says communities with a high rate of community transmission should not allow teen sports indoors or allow six feet distance. She also said that major events in those communities should be postponed.
The European Drug Administration has considered a coagulation issue that has been reported in a small number of mainly Europeans who received a vaccine developed by AstraZeneca PLC.
and Oxford University, say blood clots should be listed as a “very rare” side effect. The EMA says the benefits of the vaccine outweigh the risks.
The regulator has launched an investigation into possible links between the vaccine and coagulation incidents after some countries stopped using or restricted the use of the vaccine in certain age groups. certain.
On Tuesday, Oxford discontinued the AstraZeneca vaccine dosage in a small UK study aimed at evaluating its safety and effectiveness in children and adolescents waiting for more information on the clotting problem. , The Wall Street Journal reported. The trial started in mid-February and involved more than 200 young people from 6 to 17 years old.
But the UK government’s vaccination advisory board says adults under 30 should be offered an alternative vaccine to AstraZeneca, if it is available and they are healthy and at no risk of infection. withdraw.
Meanwhile, the UK started to roll out the first doses of the Moderna vaccine in Wales. The UK has bought enough Moderna injections for 8.5 million people, or 17 million doses of the vaccine that have been shown to be 100% effective against a serious virus in end-stage trials.
In other news:
• Anthem Inc. ANTM will pay a $ 50 incentive to any employee fully immunized against COVID-19, MarketWatch’s Tomi Kilgore reported. The health insurer said the offer would take the form of a one-time credit on health insurance premiums or donations to the Anthem Cares Foundation to help support employees in need, depending on the employee’s choice. “Anthem is committed to empowering our associates to live healthy lifestyles, so it’s important that we motivate people to get COVID-19. I am very impressed and grateful for all that our associates have done and continue to do for the customers and communities we serve, ”said Human Resources Manager Leah Stark.
• The National Institutes of Health has started one by one clinical research evaluation of allergic reaction to the COVID-19 mRNA vaccine by Moderna Inc. and BioNTech SE / Pfizer Inc. develope, MarketWatch’s Jaimy Lee reported. The aim is to understand those at increased risk, including those with a history of allergic reactions or those already diagnosed with a mast cell disorder. (Mast cells are part of the body’s immune system. When those cells mutate, it can cause one of the rare disorders.) People fit into one of three categories: people have previously reported a severe allergic reaction to a food, insect or medicine; those who have been diagnosed with a mast cell disorder; or individuals with no history of either.
• The bad news from Brazil where the death toll for the first time surpasses 4,000 a day, The Guardian reported. At least 4,195 Brazilians died on Tuesday, bringing the total to nearly 337,000, the second highest in the world after the US. Brazil also reported 86,979 new infections. Experts fear a record 100,000 Brazilians could lose their lives this month alone if they do nothing.
• One-third of COVID-19 patients develop mental or brain problems within six months of their diagnosis, in a study published Tuesday in the Lancet Psychiatry, The New York Post reported. Researchers analyzed the health records of 236,379 COVID patients, mainly from the United States, and found that 34% had been diagnosed with a neurological or psychiatric disorder six months later. About one in eight patients, or 12.8 percent, were diagnosed with such a disease for the first time, the study found. According to research, anxiety, at 17%, and depression or mood disturbances, at 14%, are the most common diagnoses.
• The pandemic has had a serious impact on the human rights of millions of people, Amnesty International says in its annual report, aggravate inequality and compromise welfare and health systems in some of the poorest countries on earth. “Whatever will be proven to be its exact origin, the coronavirus (COVID-19) and its mass casualties have grown in part thanks to our global reach of deep inequality. wider, wider within and between countries. It has been made much worse by austerity policies that undermine public infrastructure and the public health system; by the complete international architecture in form, function and leadership, ”said the human rights group.
According to global statistics for the disease caused by coronavirus increased over 132.5 million on Wednesday, according to data compiled by Johns Hopkins University, while the death toll increased by over 2.87 million.
Data shows that about 75 million people have recovered from COVID.
The US continues to lead the world in the number of cases, with 30.8 million people, or about a quarter of all global deaths and 556,529 deaths.
After Brazil, India ranks third worldwide in terms of cases with 12.8 million people and fourth in deaths at 166,177.
Mexico ranked third in the number of deaths with 204,985 people and 14th highest in the number of cases with 2.3 million people.
UK has 4.4 million cases and 127,126
China, where the virus was first detected late last year, There have been 101,928 confirmed cases and 4,841 deaths, according to its official numbers.